JNPMedi
Life Science RDC Company
Seoul, South Korea · Founded 2020 · $10.3M raised
- Headquarters
- Seoul
- Founded
- 2020
- Business Model
- B2B
- Website
- jnpmedi.com
- Total Funding
- $10.3M
- Last Round
- $10.3M Series ANov 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
JNPMEDI is a global clinical research and healthcare technology company that digitalizes how pharmaceutical clients design and manage clinical trials.
Summary
JNPMedi is a Biotech company based in Seoul, South Korea, founded in 2020. It has raised $10.3M in total across 1 round, most recently a $10.3M Series A round in Nov 2022. Investors include Pavilion Capital and Kakao Ventures.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/jnpmedi"><img src="https://indexed.vc/api/badge/company/jnpmedi" alt="JNPMedi on Indexed.vc" width="260" height="76" /></a>